179 related articles for article (PubMed ID: 38595149)
1. Central Neuromodulators in Irritable Bowel Syndrome: Why, How, and When.
Hanna-Jairala I; Drossman DA
Am J Gastroenterol; 2024 Jul; 119(7):1272-1284. PubMed ID: 38595149
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.
Black CJ; Yuan Y; Selinger CP; Camilleri M; Quigley EMM; Moayyedi P; Ford AC
Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):117-131. PubMed ID: 31859183
[TBL] [Abstract][Full Text] [Related]
3. Using the Rome IV Criteria to Help Manage the Complex IBS Patient.
Lin LD; Chang L
Am J Gastroenterol; 2018 Apr; 113(4):453-456. PubMed ID: 29257142
[No Abstract] [Full Text] [Related]
4. Central Neuromodulators for Treating Functional GI Disorders: A Primer.
Sobin WH; Heinrich TW; Drossman DA
Am J Gastroenterol; 2017 May; 112(5):693-702. PubMed ID: 28349992
[TBL] [Abstract][Full Text] [Related]
5. Antidepressants for irritable bowel syndrome-A systematic review.
Kułak-Bejda A; Bejda G; Waszkiewicz N
Pharmacol Rep; 2017 Dec; 69(6):1366-1379. PubMed ID: 29132094
[TBL] [Abstract][Full Text] [Related]
6. Psychopharmacologic Therapies for Irritable Bowel Syndrome.
Törnblom H; Drossman DA
Gastroenterol Clin North Am; 2021 Sep; 50(3):655-669. PubMed ID: 34304793
[TBL] [Abstract][Full Text] [Related]
7. Neuromodulators in the Brain-Gut Axis: their Role in the Therapy of the Irritable Bowel Syndrome.
Fadgyas Stanculete M; Dumitrascu DL; Drossman D
J Gastrointestin Liver Dis; 2021 Nov; 30(4):517-525. PubMed ID: 34812436
[TBL] [Abstract][Full Text] [Related]
8. The role of serotonin in irritable bowel syndrome: implications for management.
Garvin B; Wiley JW
Curr Gastroenterol Rep; 2008 Aug; 10(4):363-8. PubMed ID: 18627647
[TBL] [Abstract][Full Text] [Related]
9. Antidepressants in the treatment of irritable bowel syndrome and visceral pain syndromes.
Crowell MD; Jones MP; Harris LA; Dineen TN; Schettler VA; Olden KW
Curr Opin Investig Drugs; 2004 Jul; 5(7):736-42. PubMed ID: 15298070
[TBL] [Abstract][Full Text] [Related]
10. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
Lewis-Fernández R; Lam P; Lucak S; Galfalvy H; Jackson E; Fried J; Rosario M; de la Cruz AA; Sánchez-Lacay A; Díaz S; Schneier F
J Clin Psychopharmacol; 2016 Dec; 36(6):710-715. PubMed ID: 27755218
[TBL] [Abstract][Full Text] [Related]
11. Role of serotonin in gastrointestinal motility and irritable bowel syndrome.
Sikander A; Rana SV; Prasad KK
Clin Chim Acta; 2009 May; 403(1-2):47-55. PubMed ID: 19361459
[TBL] [Abstract][Full Text] [Related]
12. AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea.
Lembo A; Sultan S; Chang L; Heidelbaugh JJ; Smalley W; Verne GN
Gastroenterology; 2022 Jul; 163(1):137-151. PubMed ID: 35738725
[TBL] [Abstract][Full Text] [Related]
13. AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation.
Chang L; Sultan S; Lembo A; Verne GN; Smalley W; Heidelbaugh JJ
Gastroenterology; 2022 Jul; 163(1):118-136. PubMed ID: 35738724
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of harm in the pharmacotherapy of irritable bowel syndrome.
Shah E; Kim S; Chong K; Lembo A; Pimentel M
Am J Med; 2012 Apr; 125(4):381-93. PubMed ID: 22444104
[TBL] [Abstract][Full Text] [Related]
15. [Drug therapy for irritable bowel syndrome. What works, what doesn't work and for whom?].
Mönnikes H; Schmidtmann M; van der Voort IR
Internist (Berl); 2006 Oct; 47(10):1073-6, 1078-83. PubMed ID: 16988806
[TBL] [Abstract][Full Text] [Related]
16. Treatment of irritable bowel syndrome.
Trinkley KE; Nahata MC
J Clin Pharm Ther; 2011 Jun; 36(3):275-82. PubMed ID: 21545610
[TBL] [Abstract][Full Text] [Related]
17. Other Antidepressants.
Schwasinger-Schmidt TE; Macaluso M
Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
[TBL] [Abstract][Full Text] [Related]
18. 2008 Clinical approach to irritable bowel syndrome.
Astegiano M; Pellicano R; Sguazzini C; Berrutti M; Simondi D; Reggiani S; Rizzetto M
Minerva Gastroenterol Dietol; 2008 Sep; 54(3):251-7. PubMed ID: 18614974
[TBL] [Abstract][Full Text] [Related]
19. Implications of Pharmacogenomics to the Management of IBS.
Camilleri M
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):584-594. PubMed ID: 29709540
[TBL] [Abstract][Full Text] [Related]
20. Centrally acting therapies for irritable bowel syndrome.
Grover M; Drossman DA
Gastroenterol Clin North Am; 2011 Mar; 40(1):183-206. PubMed ID: 21333907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
